Please use this identifier to cite or link to this item:
Type: Artigo
Title: In vitro performance of free and encapsulated bromelain
Author: Ataide, Janaína Artem
Cefali, Letícia Caramori
Figueiredo, Mariana Cecchetto
Braga, Lúcia Elaine de Oliveira
Ruiz, Ana Lúcia Tasca Gois
Foglio, Mary Ann
Oliveira-Nascimento, Laura
Mazzola, Priscila Gava
Abstract: For centuries, bromelain has been used to treat a range of ailments, even though its mechanism of action is not fully understood. Its therapeutic benefits include enzymatic debridement of the necrotic tissues of ulcers and burn wounds, besides anti-inflammatory, anti-tumor, and antioxidant properties. However, the protease is unstable and susceptible to self-hydrolysis over time. To overcome the stability issues of bromelain, a previous study formulated chitosan-bromelain nanoparticles (C-B-NP). We evaluated the optimized nanoformulation for in vitro antioxidant, cell antiproliferative activities and cell migration/proliferation in the scratch assay, comparing it with free bromelain. The antioxidant activity of free bromelain was concentration and time-dependent; after encapsulation, the activity level dropped, probably due to the slow release of protein from the nanoparticles. In vitro antiproliferative activity was observed in six tumor cell lines for free protein after 48 h of treatment (glioma, breast, ovarian, prostate, colon adenocarcinoma and chronic myeloid leukemia), but not for keratinocyte cells, enabling its use as an active topical treatment. In turn, C-B-NP only inhibited one cell line (chronic myeloid leukemia) and required higher concentrations for inhibition. After 144 h treatment of glioma cells with C-B-NP, growth inhibition was equivalent to that promoted by the free protein. This last result confirmed the delayed-release kinetics of the optimized formulation and bromelain integrity. Finally, a scratch assay with keratinocyte cells showed that C-B-NP achieved more than 90% wound retraction after 24 h, compared to no retraction with the free bromelain. Therefore, nanoencapsulation of bromelain with chitosan conferred physical protection, delayed release, and wound retraction activity to the formulation, properties that favor topical formulations with a modified release. In addition, the promising results with the glioma cell line point to further studies of C-B-NP for anti-tumor treatments
Subject: Nanopartículas
Country: Reino Unido
Editor: Springer Nature
Rights: Aberto
Identifier DOI: 10.1038/s41598-021-89376-0
Date Issue: 2021
Appears in Collections:FCM - Artigos e Outros Documentos
FOP - Artigos e Outros Documentos
FCF - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
D84762B2-FB88.pdf3.17 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.